Table 2.
Stents used (n) | 48 |
Stent deployment | |
Y-configuration | 18/35 (51.4%) |
T-configuration | 17/35 (48.6%) |
Technical success | 35/35 (100%) |
Clinical success | 27/35 (77.1%) |
Decreased bilirubin levels | 27/33 (81.8%) |
Serum bilirubin decrease | 60.5% (23%-92%) |
Survival interval (d), mean (range) | 168 (0-1763) |
6-mo survival rate | 47.10% |
Primary patency (d), mean (range) | 105 ( 0-719) |
Secondary patency (d), mean (range) | 181 (100-1763) |
Peri-procedural death | 2/35 (5.7%) |
Major complications | 2/35 (5.7%) |
Minor complications | 6/35 (17.1%) |
Hospitalization time (d), mean ± SD | 10.2 ± 3.9 |